Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
doi: 10.3389/fphar.2025.1586655 Received 03 March 2025 Accepted 14 April 2025 Published 28 April 2025 Volume 16 - 2025 Edited by Jiu Chen, Nanjing University, China Reviewed by Maria Bayliak, Vasyl Stefanyk Precarpathian National University, Ukraine Imran Ahmd Khan, Jamia Hamdard University, India Updates Copyright 2025 Zhou and Wang
payer coverage of GLP-1 agonists Payers reaction to the newly approved obesity drugs suggest manufacturers are offering significant rebates to reduce the use of restrictions and even facilitate preferred access
The process is easy, convenient, and professional from start to finish
This is the piece patients describe as lifechanging
These products are high on demand in the pharmaceutical industry as well as the retail sector
US$ 29.70
US$ 27.62
US$ 20.78
